Phase 2b and Phase 3 pharma and biotech companies see extraordinary changes in their business as they progress through regulatory approval. Employee growth, SEC regulations and the need to make key decisions on manufacturing strategy, contracts and logistics can take away from the important lifesaving mission at hand. Picking a Pharma ERP system that can manage these new requirements and scale with your company's growth is one factor in a headache-free path toward commercialization.
|
|
|
|
|
|
|
|
|
|
|
|
|
50% |
Scalable |
$7m - $20m
10x
SOX 404(b)
ERP Implementation
